Treatment of neoplastic meningitis with intrathecal temozolomide

Clinical Cancer Research

Volumn 5, Issue 5, 1999, Pages 1183-1188

  Sampson, John H ^a   Archer, Gary E ^a   Villavicencio, Alan T ^c   McLendon, Roger E ^a   Friedman, Allan H ^a   Bishop, W Robert ^b   Bigner, Darell D ^a   Friedman, Henry S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TEMOZOLOMIDE;

ANIMAL MODEL; ARTICLE; BRAIN METASTASIS; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; CONTROLLED STUDY; DEMYELINATION; DRUG FORMULATION; FEMALE; GLIOMA; HISTOPATHOLOGY; INTRATHECAL DRUG ADMINISTRATION; MENINGITIS; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RAT; TOXICITY TESTING; TREATMENT OUTCOME;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; DACARBAZINE; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MENINGEAL NEOPLASMS; NEOPLASM TRANSPLANTATION; RATS; RATS, NUDE; SOLUBILITY; SUBARACHNOID SPACE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032927309     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Olson, M. E., Chernik, N. L., and Posner, J. B. Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study. Arch. Neurol., 30: 122-137, 1974.
2. Theodore, W. H., and Gendelman, S. Meningeal carcinomatosis. Arch. Neurol., 38: 696-699, 1981.
3. Wasserstrom, W. R., Glass, J. P., and Posner, J. B. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer (Phila.), 49: 759-772, 1982.
4. Ongerboer de Visser, B. W., Somers, R., Nooyen, W. H., van Heerde, P., Hart, A. A. M., and Mc Vie, J. G. Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma. Neurology, 33: 1565-1572, 1983.
5. Grossman, S. A., and Moynihan, T. J. Neoplastic meningitis. Neurol. Clin., 9: 843-856, 1991.
6. Finley, J. L. Chemotherapeutic strategies for high grade astrocytoma of childhood. In: R. J. Packer, W. A. Bleyer, and C. Pochedly (eds.), Pediatric Neuro-Oncology, pp. 176-206. Philadelphia: Harwood Academics, 1992.
7. Horspool, K. R., Stevens, M. F. G., Newton, C. G., Lunt, E., Walsh, R. J. A., Pedgrift, B. L., Baig, G. U., Lavelle, F., and Fizames, C. Antitumor imidazotetrazines. 20. Preparation of the 8-acid derivative of mitozolomide and its utility in the preparation of active antitumor agents. J. Med. Chem., 33: 1393-1399, 1990.
8. Newlands, E. S., Blackledge, G. R. P., Slack, J. A., Rustin, G. J. S., Smith, D. B., Stuart, N. S. A., Quarterman, C. P., Hoffman, R., Stevens, M. F. G., Brampton, M. H., and Gibson, A. C. Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856). Br. J. Cancer, 65: 287-291, 1992.
9. O'Reilly, S. M., Newlands, E. S., Glaser, M. G., Brampton, M., Rice-Edwards, J. M., Illingworth, R. D., Richards, P. G., Kennard, C., Colquhoun, I. R., Lewis, P., and Stevens, M. F. G. Temozolomide. A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours. Eur. J. Cancer, 29A: 940-942, 1993.
10. Frei, E., III, and Canellos, G. P. Dose. A critical factor in cancer chemotherapy. Am. J. Med., 69: 585-594, 1980.
11. Giard, D. J., Aaronson, S. A., Todaro, G. J., Arnstein, P., Kersey, J. H., Dosik, H., and Parks, W. P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst., 51: 1417-1423, 1973.
12. Friedman, H. S., Dolan, M. E., Pegg, A. E., Marcelli, S., Keir, S., Catino, J. J., Bigner, D. D., and Schold, S. C., Jr. Activity of temozolomide in the treatment of central nervous system tumor xenografts. Cancer Res., 55: 2853-2857, 1995.
13. Bigner, S. H., Mark, J., Schold, S. C., Jr., Eng, L. F., and Bigner, D. D. A serially transplantable human giant cell glioblastoma that maintains a near-haploid stem line. Cancer Genet. Cytogenet., 18: 141-153, 1985.
14. Friedman, H. S., Dolan, M. E., Moschel, R. C., Pegg, A. E., Felker, G. M., Rich, J., Bigner, D. D., and Schold, S. C., Jr. Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme. J. Natl. Cancer Inst., 84: 1926-1931, 1992.
15. 6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Chemother. Pharmacol., 39: 307-316, 1997.
16. Fuchs, H. E., Archer, G. E., Colvin, O. M., Bigner, S. H., Schuster, J. M., Fuller, G. N., Muhlbaier, L. H., Schold, S. C., Jr., Friedman, H. S., and Bigner, D. D. Activity of intrathecal 4-hydroperoxycyclophosphamide in a nude rat model of human neoplastic meningitis. Cancer Res., 50: 1954-1959, 1990.
17. Meek, J. L., and Neff, N. H. Is cerebrospinal fluid the major avenue for the removal of 5-hydroxyindoleacetic acid from the brain? Neuropharmacology, 12: 497-499, 1973.
18. Kooistra, K. L., Rodriguez, M., Powis, G., Yaksh, T. L., Harty, G. J., Hilton, J. F., and Laws, E. R., Jr. Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat. Cancer Res., 46: 317-323, 1986.
19. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
20. Friedman, H. S., Archer, G. E., McLendon, R. E., Schuster, J. M., Colvin, O. M., Guaspari, A., Blum, R., Savina, P. A., Fuchs, H. E., and Bigner, D. D. Intrathecal melphalan therapy of human neoplastic meningitis in athymic nude rats. Cancer Res., 54: 4710-4714, 1994.
21. Archer, G. E., Sampson, J. H., McLendon, R. E., Fuchs, H. E., Colvin, O. M., McCullough, W., Parikh, I., Clement, M., Bigner, D. D., and Friedman, H. S. Treatment of neoplastic meningitis with intrathecal Spartaject™-busulfan. Proc. Am. Assoc. Cancer Res., 37: 298, 1996.
22. Stevens, M. F. G., Hickman, J. A., Langdon, S. P., Chubb, D., Vickers, L., Stone, R., Baig, G., Goddard, C., Gibson, N. W., Slack, J. A., Newton, C., Lunt, E., Fizames, C., and Lavelle, F. Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine. Cancer Res., 47: 5846-5852, 1987.
23. Newlands, E. S., Blackledge, G., Slack, J. A., Goddard, C., Brindley, C. J., Holden, L., and Stevens, M. F. G. Phase I clinical trial of mitozolomide. Cancer Treat. Rep., 69: 801-805, 1985.
24. Newton, H. B., Junck, L., Bromberg, J., Page, M. A., and Greenberg, H. S. Procarbazine chemotherapy in the treatment of recurrent malignant astrocytomas after radiation and nitrosourea failure. Neurology, 40: 1743-1746, 1990.
25. Rodriguez, L. A., Prados, M., Silver, P., and Levin, V. A. Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors. Cancer (Phila.), 64: 2420-2423, 1989.
26. Green, S. B., Byar, D. P., Walker, M. D., Pistenmaa, D. A., Alexander, E. J., Batzdorf, U., Brooks, W. H., Hunt, W. E., Mealey, J. J., Odom, G. L., Paoletti, P., Ransohoff, J., II, Robertson, J. T., Selker, R. G., Shapiro, W. R., Smith, K. R. J., Wilson, C. B., and Strike, T. A. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat. Rep., 7: 121-132, 1983.
27. Kumar, A. R. V., Renaudin, J., Wilson, C. B., Boldrey, E. B., Enot, K. J., and Levin, V. A. Procarbazine hydrochloride in the treatment of brain tumors. Phase 2 study. J. Neurosurg., 40: 365-371, 1974.
28. Edwards, M. S., Levin, V. A., and Wilson, C. B. Brain tumor chemotherapy: an evaluation of agents in current use for phase II and III trials. Cancer Treat. Rep., 64: 1179-1205, 1980.
29. Hall, W. A., Myklebust, A., Godal, A., Nesland, J. M., and Fodstad, O. In vivo efficacy of intrathecal transferrin-Pseudomonas exotoxin A immunotoxin against LOX melanoma. Neurosurgery, 34: 649-655, 1994.
30. Youle, R. J. Immunotoxins for central nervous system malignancy. Semin. Cancer Biol., 7: 65-70, 1996.
31. Friedman, H. S., Ochs, J., Finlay, J., Geyer, R., Arndt, C., Cohen, B., Philips, P., Strauss, L. C., Hochberg, F., Schold, S. C., Bigner, D. D., and Colvin, O. M. Phase 1 trial of intrathecal 4-hydroperoxycyclophosphamide for neoplastic meningitis. Proc. Am. Assoc. Cancer Res., 34: 269, 1993.
32. Devineni, D., Klein-Szanto, A., and Gallo, J. M. Uptake of temozolomide in a rat glioma model in the presence and absence of the angiogenesis inhibitor TNP-470. Cancer Res., 56: 1983-1987, 1996.
33. Snyder, W. S., Cook, M. J., Nasset, E. S., Karhausen, L. R., Howells, G. P., and Tipton, I. H. Report of the Task Group on Reference Man, p. 219. Oxford: Pergamon Press, 1986.
34. Tsang, L. L., Quarterman, C. P., Gescher, A., and Slack, J. A. Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamide. Cancer Chemother. Pharmacol., 27: 342-346, 1991.